Laura Naldi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Laura Naldi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular and Cellular Endocrinology|August 14, 2021

Low sodium and tolvaptan have opposite effects in human small cell lung cancer cellsGiada Marroncini, Cecilia Anceschi, Laura Naldi, et al.

International Journal of Molecular Sciences|August 10, 2024

The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung CancerLaura Naldi, Benedetta Fibbi, Simone Polvani, et al.

Biomedicines|August 28, 2025

Targeting CEACAM5: Biomarker Characterization and Fluorescent Probe Labeling for Image-Guided Gastric Cancer SurgerySerena Martinelli, Sara Peri, Cecilia Anceschi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular and Cellular Endocrinology|August 14, 2021

Low sodium and tolvaptan have opposite effects in human small cell lung cancer cellsGiada Marroncini, Cecilia Anceschi, Laura Naldi, et al.

International Journal of Molecular Sciences|August 10, 2024

The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung CancerLaura Naldi, Benedetta Fibbi, Simone Polvani, et al.

Biomedicines|August 28, 2025

Targeting CEACAM5: Biomarker Characterization and Fluorescent Probe Labeling for Image-Guided Gastric Cancer SurgerySerena Martinelli, Sara Peri, Cecilia Anceschi, et al.

Pageof 2